109 related articles for article (PubMed ID: 10342323)
1. A direct method for the calculation of alloreactive CD4+ T cell precursor frequency.
Noorchashm H; Lieu YK; Rostami SY; Song HK; Greeley SA; Bazel S; Barker CF; Naji A
Transplantation; 1999 May; 67(9):1281-4. PubMed ID: 10342323
[TBL] [Abstract][Full Text] [Related]
2. Tracking alloreactive cell division in vivo.
Song HK; Noorchashm H; Lieu YK; Rostami S; Greeley SA; Barker CF; Naji A
Transplantation; 1999 Jul; 68(2):297-9. PubMed ID: 10440405
[TBL] [Abstract][Full Text] [Related]
3. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.
Suchin EJ; Langmuir PB; Palmer E; Sayegh MH; Wells AD; Turka LA
J Immunol; 2001 Jan; 166(2):973-81. PubMed ID: 11145675
[TBL] [Abstract][Full Text] [Related]
4. "Pruning" of alloreactive CD4+ T cells using 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester prolongs skin allograft survival.
Watson D; Zhang GY; Sartor M; Alexander SI
J Immunol; 2004 Dec; 173(11):6574-82. PubMed ID: 15557147
[TBL] [Abstract][Full Text] [Related]
5. Alloreactive CD4 T cell activation in vivo: an autonomous function of the indirect pathway of alloantigen presentation.
Reed AJ; Noorchashm H; Rostami SY; Zarrabi Y; Perate AR; Jeganathan AN; Caton AJ; Naji A
J Immunol; 2003 Dec; 171(12):6502-9. PubMed ID: 14662850
[TBL] [Abstract][Full Text] [Related]
6. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
Foucras G; Coudert JD; Coureau C; Guéry JC
J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo.
Krieger NR; Fathman CG; Shaw MK; Ridgway WM
Transplantation; 2000 Feb; 69(4):605-9. PubMed ID: 10708118
[TBL] [Abstract][Full Text] [Related]
9. Activated allogeneic NK cells as suppressors of alloreactive responses.
Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
[TBL] [Abstract][Full Text] [Related]
10. Completely allogeneic spleen cells induced cytolytic neonatal tolerance to alloantigens, but failed to establish allo-helper interactions with host T cells.
Ramos A; González M; López-Hoyos M; Carrió R; Merino J
Immunology; 1996 Nov; 89(3):413-8. PubMed ID: 8958055
[TBL] [Abstract][Full Text] [Related]
11. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
12. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
13. Induction of acute graft-versus-host disease by T cells that do not respond to in vitro alloantigen stimulation.
New JY; Chan SH; Yap EH; Hu H
Br J Haematol; 2004 Sep; 126(6):828-36. PubMed ID: 15352987
[TBL] [Abstract][Full Text] [Related]
14. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
[TBL] [Abstract][Full Text] [Related]
15. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens.
Coudert JD; Coureau C; Guéry JC
J Immunol; 2002 Sep; 169(6):2979-87. PubMed ID: 12218112
[TBL] [Abstract][Full Text] [Related]
16. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
17. Low level lead exposure in vitro stimulates the proliferation and expansion of alloantigen-reactive CD4(high) T cells.
McCabe MJ; Singh KP; Reiners JJ
Toxicol Appl Pharmacol; 2001 Dec; 177(3):219-31. PubMed ID: 11749121
[TBL] [Abstract][Full Text] [Related]
18. Precursor frequency, nonlinear proliferation, and functional maturation of virus-specific CD4+ T cells.
Whitmire JK; Benning N; Whitton JL
J Immunol; 2006 Mar; 176(5):3028-36. PubMed ID: 16493061
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells.
Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH
J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
